, Ziad A. Massy 1,2,8 , Bénédicte Stengel 1,2* , Patrick Rossignol 2,9 and for the NephroTest Study group
In the original version of this article [1] , published on 12 September 2017, the explanation of a and b in the footnote of Table 2 were switched during typesetting. In this Correction Table 2 , the incorrect and correct version of its footnote are shown. The affected part of the footnote is marked in italics. The original publication of this article has been corrected. ACEi or ARBs or potassium-sparing diuretics BMI body mass index, CVD cardiovascular disease, mGFR measured GFR, ACR, ratio of urinary albumin to creatinine The analyses was adjusted for center loop or thiazide diuretic, kayexalate or bicarbonates BMI, body mass index, CVD, cardiovascular disease, mGFR, measured GFR, ACR, ratio of urinary albumin to creatinine The analyses was adjusted for center
